Count | |
18 | |
12 | |
1 | |
1 | |
Dopamine Agonists/administration & dosage/pharmacology/*therapeutic use | 1 |
Dopamine Agonists/administration & dosage/*pharmacokinetics/*pharmacology | 1 |
Dopamine Agonists/chemical synthesis/chemistry/metabolism/pharmacology | 1 |
3 | |
1 | |
3 | |
29 | |
1 | |
3 | |
3 | |
1 | |
1 | |
12 | |
1 | |
1 | |
3 | |
3 | |
1 | |
3 | |
1 | |
1 | |
Receptors, Dopamine D2/agonists/antagonists & inhibitors/metabolism | 1 |
Receptors, Dopamine D1/agonists/antagonists & inhibitors/*metabolism | 1 |
Receptors, Dopamine D2/agonists/antagonists & inhibitors/*metabolism | 2 |
Dopamine Agonists/adverse effects/*pharmacokinetics/therapeutic use | 1 |
1 | |
37 | |
28 | |
14 | |
1 | |
1 | |
10 | |
1 | |
1 | |
1 | |
3 | |
9 | |
1 | |
9 | |
4 | |
1 | |
1 | |
1 | |
1 | |
1 | |
1 | |
2 | |
1 | |
1 | |
2 | |
3 | |
1 | |
1 | |
1 | |
1 | |
Dopamine/analogs & derivatives/*pharmacology/therapeutic use | 1 |
1 | |
1 | |
1 | |
1 | |
Dopamine Agents/adverse effects/pharmacokinetics/*pharmacology | 1 |
Dopamine Antagonists/chemical synthesis/metabolism/*pharmacology | 1 |
Dopamine Antagonists/chemical synthesis/chemistry/metabolism/pharmacology | 1 |
2 | |
2 | |
1 | |
7 | |
1 | |
1 | |
1 | |
1 | |
1 | |
7 | |
7 | |
1 | |
1 | |
34 | |
5 | |
3 | |
1 | |
1 | |
3 | |
6 | |
8 | |
1 | |
24 | |
1 | |
10 | |
1 | |
1 | |
12 | |
1 | |
1 | |
2 | |
22 | |
3 | |